InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the full record of transactions filed by Lis William, Director. Director active across 2 companies, notably Zai Lab Ltd. Cumulatively, 6 disclosures have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €229k. History available since 3 January 2022. The latest transaction was filed on 24 June 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
24,743 shares@ US$2.0220.22% mcap100.0% of flowVoting Common StockSEC:0001213900-22-035570:0
89,972 shares0Voting Common StockSEC:0001213900-22-014562:0
1,926 shares@ US$53.400.0039% mcap100.0% of flowOrdinary SharesSEC:0001567619-22-001445
1,926 shares@ US$53.400.0039% mcap50.0% of flowOrdinary SharesSEC:0001567619-22-001445:0
7,763 shares0Ordinary SharesSEC:0001567619-22-000397
7,763 shares0Ordinary SharesSEC:0001567619-22-000397:0
6 of 6 declarations
About Lis William
William Lis is a Director at Zai Lab Ltd and Jasper Therapeutics, Inc. As a board member, he participates in strategic decision-making and oversight of the companies' activities. His experience in the biopharmaceutical sector allows him to provide informed perspectives on industry challenges. He is committed to ensuring compliance and promoting best governance practices within the organizations.
